Artificial Intelligence and Digital Pathology for Molecular Classification of Endometrial Cancer
International Journal of Molecular Sciences · 17.08.2026 · 27 (16) · 7341
DOI: 10.3390/ijms27167341 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.08.2026. Verfasst von Yesul Jeong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pathology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Artificial Intelligence. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean government, Ministry of Health & Welfare, Republic of Korea.
Abstract (Originalsprache)
Endometrial cancer is one of the most rapidly increasing gynaecological malignancies worldwide. The clinically adapted molecular classification of endometrial carcinoma, derived from The Cancer Genome Atlas, comprises four major subtypes: POLE-mutated, mismatch repair-deficient, p53-abnormal expression, and no specific molecular profile. Its clinical implementation has improved prognostic stratification, risk assessment, and treatment decision-making in patients with endometrial carcinoma. However, current workflows rely on immunohistochemistry and targeted sequencing, which increase costs, turnaround times, and infrastructure requirements, thereby limiting their universal adoption in routine clinical practice. Recent advances in artificial intelligence (AI), particularly deep learning models capable of predicting molecular features directly from H&E-stained whole-slide images, have emerged as promising tools for precision oncology. In addition to reproducing established molecular classification, these approaches may reveal previously unrecognised biomarker-defined histologic patterns that are difficult to detect using conventional methods. This article synthesises the current evidence on AI-based molecular classification in endometrial carcinoma from a pathologist-centred perspective, emphasising the biological rationale, methodological limitations, and future directions for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hospital Pathology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Biomedical Informatics, College of Medicine, Korea University, Seoul 02841, Republic of Korea.
- Department of Pathology, College of Medicine, Korea University, Seoul 02841, Republic of Korea.
- Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Yesul Jeong, Sung Hak Lee
Förderung
- Korean government
- Ministry of Health & Welfare, Republic of Korea
Zitieren
APA
Jeong, Y., Hong, S., Ahn, S., & Lee, S. H. (2026). Artificial Intelligence and Digital Pathology for Molecular Classification of Endometrial Cancer. International Journal of Molecular Sciences, 27(16), 7341. https://doi.org/10.3390/ijms27167341
Vancouver
Jeong Y, Hong S, Ahn S, Lee SH. Artificial Intelligence and Digital Pathology for Molecular Classification of Endometrial Cancer. International Journal of Molecular Sciences. 2026;27(16):7341. doi:10.3390/ijms27167341
BibTeX
@article{Jeong2026,
author = {Jeong, Yesul and Hong, Sungman and Ahn, Sangjeong and Lee, Sung Hak},
title = {Artificial Intelligence and Digital Pathology for Molecular Classification of Endometrial Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {16},
pages = {7341},
doi = {10.3390/ijms27167341}
}
EUVIMED